Opthalmology, Centro Hospitalar do Porto, Porto, Portugal.
Amyloid. 2011 Sep;18(3):92-7. doi: 10.3109/13506129.2011.576719. Epub 2011 May 19.
The aim of this study was to evaluate if Portuguese patients with familial amyloidosis, liver transplanted and not, have an earlier development of presbyopia compared with a normal population and its relation with the presence or the absence of anterior capsule opacification of the lens. This study was performed to evaluate if Portuguese patients with familial amyloidosis and in a blood donors population (control group). Three hundred and fifty-six subjects, 144 amyloidotic patients and 212 healthy individuals, were evaluated for the need of plus lenses for normal near reading (Jaeger chart 1 at 33 cm). In familial amyloidosis patients, the value of the add-power was related to age, liver transplantation status, and presence of visible anterior capsule opacification of the lens. In both groups, the value of add-power was positively correlated with age (r=0.91; P<0.005). Familial amyloidosis patients require more add-power than control individuals of similar age, and need to use reading glasses at earlier ages. The age of onset of presbyopia in familial amyloidosis patients was significantly lower than in control individuals (32 years vs. 42 years). Adjusting for age, no significant difference was observed in add-power values between liver transplanted and not transplanted amyloidotic patients, suggesting that liver transplantation has no influence on presbyopia evolution in these patients. Familial amyloidosis patients had an earlier onset of presbyopia, probably related to amyloid deposition on the anterior capsule of the lens, which is not halted by liver transplantation.
本研究旨在评估葡萄牙家族性淀粉样变性肝移植患者与正常人群相比是否更早出现老视,以及其与晶状体前囊混浊的存在与否的关系。该研究评估了葡萄牙家族性淀粉样变性患者(病例组)和献血者人群(对照组)。对 356 名受试者(144 名淀粉样变性患者和 212 名健康个体)进行了评估,以确定他们是否需要正镜片进行正常的近距阅读(Jaeger 图表 1 在 33 厘米处)。在家族性淀粉样变性患者中,附加光度值与年龄、肝移植状态和晶状体前囊混浊的存在有关。在两组中,附加光度值与年龄呈正相关(r=0.91;P<0.005)。与年龄相近的对照组个体相比,家族性淀粉样变性患者需要更多的附加光度,并且更早需要使用阅读眼镜。家族性淀粉样变性患者老视的发病年龄明显低于对照组(32 岁 vs. 42 岁)。校正年龄后,肝移植和未移植淀粉样变性患者的附加光度值无显著差异,提示肝移植对这些患者的老视进展无影响。家族性淀粉样变性患者老视的发病年龄更早,可能与晶状体前囊的淀粉样沉积有关,而肝移植并不能阻止这种沉积。